Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

More Pharma, R&D for Lonza

September 19, 2005 | A version of this story appeared in Volume 83, Issue 38

Lonza will expand capacity for active pharmaceutical ingredients in Visp, Switzerland. A $20 million first phase, to be completed during 2006, will include a new building and enlarged drying capacity. The firm later plans two production trains for final products and up to three drying trains. Separately, the company is building a new R&D center in Nansha near Guangzhou, China. The center, to house about 60 scientific personnel, is expected to open in the first quarter of next year. An existing R&D group in Guangzhou will relocate there.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.